Clearance of pathogens or tumor cells by antibodies traditionally requires both Fab and Fc domains of IgG. Here, we show the Fc domain of IgG alone mediates recognition and clearance of herpes simplex virus (HSV1)-infected cells. The human natural killer (NK) cell surface is naturally coated with IgG bound by its Fc domain to the Fcγ receptor CD16a. NK cells utilize the Fc domain of bound IgG to recognize gE, an HSV1-encoded glycoprotein that also binds the Fc domain of IgG but at a site distinct from CD16a. The bridge formed by the Fc domain between the HSV1-infected cell and the NK cell results in NK cell activation and lysis of the HSV1-infected cell in the absence of HSV1-specific antibody in vitro and prevents fatal HSV1 infection in vivo. This mechanism also explains how bacterial IgG-binding proteins regulate NK cell function and may be broadly applicable to Fcγ-receptor-bearing cells.
Pubmed ID: 28723548 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This unknown targets CD3
View all literature mentionsThis unknown targets Human IgG1 Kappa Control
View all literature mentionsThis unknown targets Human IgG3 Kappa Control
View all literature mentionsThis monoclonal targets CD120a (TNF-RI)
View all literature mentionsThis unknown targets Asialo-GM1
View all literature mentionsThis unknown targets CD247, phospho (Tyr142)
View all literature mentionsThis monoclonal targets CD247
View all literature mentionsThis monoclonal targets HSV1 gE Envelope Protein
View all literature mentionsThis monoclonal targets IFN-γ
View all literature mentionsThis unknown targets Human IgG, Fc? Fragment Specific
View all literature mentionsThis isotype control targets not applicable
View all literature mentionsThis monoclonal targets CD16
View all literature mentionsThis monoclonal targets CD107a
View all literature mentionsThis monoclonal targets CD62L
View all literature mentionsThis monoclonal targets CD69
View all literature mentionsThis monoclonal targets CD56
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentionsMus musculus with name BALB/cJ from IMSR.
View all literature mentions